Pharmacological Inhibition of the Chemokine Receptor, CX3CR1, Reduces Atherosclerosis in Mice

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2013-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/ATVBAHA.112.300930PMID 23887641
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contribution of Platelet CX3CR1 to Platelet–Monocyte Complex Formation and Vascular Recruitment During Hyperlipidemia

  2012cited by this paper
• Pharmacological Inhibition of C-C Chemokine Receptor 2 Decreases Macrophage Infiltration in the Aortic Root of the Human C-C Chemokine Receptor 2/Apolipoprotein E−/− Mouse: Magnetic Resonance Imaging Assessment

  2010cited by this paper
• CCR2 receptor blockade alters blood monocyte subpopulations but does not affect atherosclerotic lesions in apoE(-/-) mice.

  2010cited by this paper
• An engineered CX3CR1 antagonist endowed with anti‐inflammatory activity

  2009cited by this paper
• Immune and inflammatory mechanisms of atherosclerosis (*).

  2009cited by this paper
• CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival.

  2009influential reference
• Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6Chi and Ly6Clo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice

  2008cited by this paper
• Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

  2008cited by this paper
• Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

  2008cited by this paper
• Fractalkine Deficiency Markedly Reduces Macrophage Accumulation and Atherosclerotic Lesion Formation in CCR2−/− Mice: Evidence for Independent Chemokine Functions in Atherogenesis

  2008cited by this paper
• Functional Adhesiveness of the CX3CL1 Chemokine Requires Its Aggregation

  2008cited by this paper
• A Novel RANTES Antagonist Prevents Progression of Established Atherosclerotic Lesions in Mice

  2008cited by this paper
• Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata.

  2007cited by this paper
• Chemokine regulation of atherosclerosis

  2007cited by this paper
• Monocyte/Macrophage Suppression in CD11b Diphtheria Toxin Receptor Transgenic Mice Differentially Affects Atherogenesis and Established Plaques

  2007cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

  2007cited by this paper
• CX3CR1 Deficiency Impairs Dendritic Cell Accumulation in Arterial Intima and Reduces Atherosclerotic Burden

  2007cited by this paper
• Monitoring of Blood Vessels and Tissues by a Population of Monocytes with Patrolling Behavior

  2007cited by this paper
• Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques.

  2007cited by this paper
• Ccr5 But Not Ccr1 Deficiency Reduces Development of Diet-Induced Atherosclerosis in Mice

  2006cited by this paper
• Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissues.

  2006cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

  2005cited by this paper
• Subpopulations of Mouse Blood Monocytes Differ in Maturation Stage and Inflammatory Response1

  2004cited by this paper
• Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root.

  2004cited by this paper
• Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in Mice

  2004cited by this paper
• Chemokines: Key Regulators of Mononuclear Cell Recruitment in Atherosclerotic Vascular Disease

  2004cited by this paper
• Decreased Atherosclerotic Lesion Formation in CX3CR1/Apolipoprotein E Double Knockout Mice

  2003cited by this paper
• Blood monocytes consist of two principal subsets with distinct migratory properties.

  2003cited by this paper
• Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.

  2003cited by this paper
• Smooth Muscle Cells in Human Atherosclerotic Plaques Express the Fractalkine Receptor CX3CR1 and Undergo Chemotaxis to the CX3C Chemokine Fractalkine (CX3CL1)

  2003cited by this paper
• Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans.

  2003cited by this paper
• The fractalkine receptor CX3CR1 is a key mediator of atherogenesis.

  2003cited by this paper
• Macrophage Depletion by Clodronate-Containing Liposomes Reduces Neointimal Formation After Balloon Injury in Rats and Rabbits

  2002cited by this paper
• Association Between Polymorphism in the Chemokine Receptor CX3CR1 and Coronary Vascular Endothelial Dysfunction and Atherosclerosis

  2001cited by this paper
• Atherosclerosis The Road Ahead

  2001cited by this paper
• Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease.

  2001cited by this paper
• Analysis of Fractalkine Receptor CX3CR1 Function by Targeted Deletion and Green Fluorescent Protein Reporter Gene Insertion

  2000cited by this paper
• Atherosclerosis : Vascular biology

  2000cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis

  1998cited by this paper
• Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.

  1998cited by this paper
• Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E.

  1995cited by this paper
• Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages.

  1979cited by this paper

• Cx3cr1 depletion ameliorates lipid metabolic dysregulation and pulmonary fibrosis induced by silica.

  2026cites this paper
• Chemokine Fractalkine and Non-Obstructive Coronary Artery Disease—Is There a Link?

  2024cites this paper
• Association of monocyte to HDL cholesterol ratio and a composite risk score with left ventricular aneurysm formation in patients with acute ST-segment elevation myocardial infarction

  2024cites this paper
• Targeting immune cell recruitment in atherosclerosis

  2024cites this paper
• Elucidating the role of chemokines in inflammaging associated atherosclerotic cardiovascular diseases.

  2024cites this paper
• Cross Talks between CNS and CVS Diseases: An Alliance to Annihilate

  2024cites this paper
• Peritoneal Dialysis Aggravates and Accelerates Atherosclerosis in Uremic ApoE −/− Mice

  2024cites this paper
• Mild Hypoxia Accelerates Cerebral Cavernous Malformation Disease Through CX3CR1-CX3CL1 Signaling

  2024cites this paper
• Atherosclerosis from Newborn to Adult—Epidemiology, Pathological Aspects, and Risk Factors

  2023cites this paper
• Monocyte chemokine receptors as therapeutic targets in cardiovascular diseases.

  2023cites this paper
• Fractalkine Signalling (CX3CL1/CX3CR1 Axis) as an Emerging Target in Coronary Artery Disease

  2023cites this paper
• CD11b+CD43hiLy6Clo splenocyte‐derived macrophages exacerbate liver fibrosis via spleen–liver axis

  2022cites this paper
• Cytokines associated with immune response in atherosclerosis.

  2022cites this paper
• Macrophages in Atheromatous Plaque Developmental Stages

  2022influential citation
• The Impact of Cytokines in Coronary Atherosclerotic Plaque: Current Therapeutic Approaches

  2022cites this paper
• Key Chemokine Pathways in Atherosclerosis and Their Therapeutic Potential

  2021cites this paper
• Targeting the chemokine network in atherosclerosis.

  2021cites this paper
• Targeting macrophages using nanoparticles: a potential therapeutic strategy for atherosclerosis.

  2021cites this paper
• Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting

  2021cites this paper
• Nature versus Number: Monocytes in Cardiovascular Disease

  2021cites this paper
• Contemporary Lifestyle and Neutrophil Extracellular Traps: An Emerging Link in Atherosclerosis Disease

  2021cites this paper
• Increased fractalkine and vascular dysfunction in obesity and in type 2 diabetes. Effects of oral antidiabetic treatment.

  2020cites this paper
• The CX3CL1/CX3CR1 axis is up-regulated in chronic kidney disease and contributes to angiotensin II-induced migration of vascular smooth muscle cells.

  2020cites this paper
• Glial Cell-Axonal Growth Cone Interactions in Neurodevelopment and Regeneration

  2020cites this paper
• Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019

  2020cites this paper
• Low Shear Stress Upregulates CX3CR1 Expression by Inducing VCAM-1 via the NF-κB Pathway in Vascular Endothelial Cells

  2020cites this paper
• Adoptive transfer of CX3CR1 transduced-T regulatory cells improves homing to the atherosclerotic plaques and dampens atherosclerosis progression.

  2020cites this paper
• Human CD16+ monocytes promote a pro-atherosclerotic endothelial cell phenotype via CX3CR1-CX3CL1 interaction.

  2020cites this paper
• The Role of Spinal Cord CX3CL1/CX3CR1 Signalling in Chronic Pain

  2020cites this paper
• New insights on repeated acoustic injury: Augmentation of cochlear susceptibility and inflammatory reaction resultant of prior acoustic injury.

  2020cites this paper
• Suppressor of Cytokine Signaling 1 is Involved in Gene Regulation Which Controls the Survival of Ly6Clow Monocytes in Mice.

  2019cites this paper
• Loss of 2 Akt (Protein Kinase B) Isoforms in Hematopoietic Cells Diminished Monocyte and Macrophage Survival and Reduces Atherosclerosis in Ldl Receptor-Null Mice

  2019cites this paper
• Chapter 2 Cytokines and Immune Responses in Murine Atherosclerosis

  2019cites this paper
• Indispensable Role of CX3CR1+ Dendritic Cells in Regulation of Virus-Induced Neuroinflammation Through Rapid Development of Antiviral Immunity in Peripheral Lymphoid Tissues

  2019cites this paper
• Endogenous glucocorticoids prevent gastric metaplasia by suppressing spontaneous inflammation

  2019cites this paper
• Chemokines as Therapeutic Targets in Cardiovascular Disease: The Road Behind, The Road Ahead

  2019cites this paper
• Influence of laminar shear stress on transmembrane chemokines and proteases of the ADAM family in endothelial cells

  2018cites this paper
• Metabolic Network 10-17-2016 CXCR 4 identifies transitional bone marrow premonocytes that replenish the mature monocyte pool for peripheral responses

  2018cites this paper
• The homozygous CX 3 CR 1M 280 mutation impairs human monocyte survival

  2018cites this paper
• The homozygous CX3CR1-M280 mutation impairs human monocyte survival.

  2018cites this paper
• DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in mice

  2018cites this paper
• The Ins and Outs of Myeloid Cells in Atherosclerosis

  2018cites this paper
• CX3CL1-Fc treatment prevents atherosclerosis in Ldlr KO mice

  2018cites this paper
• Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension

  2017cites this paper
• Monocyte inflammatory profile is specific for individuals and associated with altered blood lipid levels.

  2017cites this paper
• CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis

  2017cites this paper
• CX3CR1 ablation ameliorates motor and respiratory dysfunctions and improves survival of a Rett syndrome mouse model.

  2017cites this paper
• Role of the CX3C chemokine receptor CX3CR1 in the pathogenesis of atherosclerosis after aortic transplantation

  2017cites this paper
• Shear Stress Counteracts Endothelial CX3CL1 Induction and Monocytic Cell Adhesion

  2017cites this paper
• CX3CR1-dependent endothelial margination modulates Ly6Chigh monocyte systemic deployment upon inflammation in mice.

  2017cites this paper
• The role of fractalkine – CX3CR1 signaling in the development of obesity

  2017cites this paper
• A rapid monocyte response team.

  2017cites this paper
• Killer cells in atherosclerosis

  2017cites this paper
• Association of the Fractalkine Level with Non-modifiable and Modifiable Factors of Cardiovascular Risk, the Severity of the Atherosclerotic Lesions of the Coronary Vessels

  2016cites this paper
• Cytokines: roles in atherosclerosis disease progression and potential therapeutic targets.

  2016cites this paper
• T Cell CX3CR1 Mediates Excess Atherosclerotic Inflammation in Renal Impairment.

  2016cites this paper
• Lu and Daugherty Atherosclerosis in ATVB 487 Resident Cell Types in Atherosclerosis Endothelial Cell – Specific Effects

  2016cites this paper
• The Effect of Wenxin Keli on the mRNA Expression Profile of Rabbits with Myocardial Infarction

  2016cites this paper
• Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells

  2016cites this paper
• CX3CR1 deficiency delays acute skeletal muscle injury repair by impairing macrophage functions

  2016cites this paper
• Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE −/− Mice

  2016cites this paper
• Generating Chemokine Analogs with Enhanced Pharmacological Properties Using Phage Display.

  2016cites this paper
• Effect of Combination Therapy with Alpha-Lipoic Acid on the Fractalkine Level in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus

  2016cites this paper
• CXCR4 identifies transitional bone marrow premonocytes that replenish the mature monocyte pool for peripheral responses

  2016cites this paper
• Recent Highlights of ATVB

  2016cites this paper
• identifies that replenish the mature pool for peripheral responses.

  2016cites this paper
• CXCR 4 identifies transitional bone marrow premonocytes that replenish the mature monocyte pool for peripheral responses

  2016cites this paper
• Etude du signal AMP cyclique déclenché par la chimiokine CX3CL1 en aval de son récepteur CX3CR1

  2015cites this paper
• T Cells with Distinct Migratory Capacities to + Effector Memory CD8 high α and IL-7R low α Expression of CX3CR1 on Human IL-7R DNA Methylation Regulates the Differential

  2015cites this paper
• the Fractalkine T Cells with Distinct Migratory Capacities to + Effector Memory CD8 high a and IL-7R low a Expression of CX3CR1 on Human IL-7R DNA Methylation Regulates the Differential

  2015cites this paper
• Recent Highlights of ATVB

  2015cites this paper
• Regulation of atherosclerotic plaque inflammation

  2015cites this paper
• Cytokines and Immune Responses in Murine Atherosclerosis.

  2015cites this paper
• Role of Fractalkine / CX 3 CL 1 and Its Receptor in the Pathogenesis of Inflammatory and Malignant Diseases with Emphasis on B Cell Malignancies

  2015cites this paper
• the Fractalkine T Cells with Distinct Migratory Capacities to + Effector Memory CD8 high a and IL-7R low a Expression of CX3CR1 on Human IL-7R DNA Methylation Regulates the Differential

  2015cites this paper
• CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis.

  2015cites this paper
• Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets

  2015cites this paper
• Advances in non-invasive drug delivery for atherosclerotic heart disease

  2015cites this paper
• Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease.

  2015cites this paper
• AZD8797 is an allosteric non-competitive modulator of the human CX3CR1 receptor

  2015cites this paper
• Cx3cr1 deficiency in mice attenuates hepatic granuloma formation during acute schistosomiasis by enhancing the M2-type polarization of macrophages

  2015cites this paper
• DNA Methylation Regulates the Differential Expression of CX3CR1 on Human IL-7Rαlow and IL-7Rαhigh Effector Memory CD8+ T Cells with Distinct Migratory Capacities to the Fractalkine

  2015cites this paper
• HIV-Infection, Atherosclerosis and the Inflammatory Pathway: Candidate Gene Study in a Spanish HIV-Infected Population

  2014cites this paper
• Nouvelles Voies de Régulation contrôlant l'Homéostasie Lipidique et l'Inflammation dans le Macrophage Humain au cours de l'Athérosclérose

  2014cites this paper
• Human Immunodeficiency Virus infection, asymptomatic atherosclerosis, and inflammation: A candidate gene study

  2014cites this paper
• Chemokines in Atherosclerosis: Proceedings Resumed

  2014influential citation
• Molecular and functional interactions among monocytes/macrophages and smooth muscle cells and their relevance for atherosclerosis.

  2014cites this paper
• Fractalkine (CX3CL1), GM-CSF and VEGF-a levels are reduced by statins in adult patients

  2014cites this paper
• Vascular smooth muscle cells and monocyte-macrophages accomplice in the accelerated atherosclerosis of insulin resistance states.

  2014cites this paper
• Innate immunity in atherosclerosis : the role of pattern recognition receptors

  2014cites this paper
• Macrophages

  2014cites this paper
• Fractalkine Promotes Human Monocyte Survival via a Reduction in Oxidative Stress

  2014cites this paper
• Role of Fractalkine/CX3CL1 and Its Receptor in the Pathogenesis of Inflammatory and Malignant Diseases with Emphasis on B Cell Malignancies

  2014cites this paper
• Recent Highlights of ATVB

  2014cites this paper
• Chemokines

  1997cites this paper
• Monocyte and Neutrophil Recruitment to Atherosclerotic Vessels—where Do We Stand? Chemokines and Their Receptors Revisited Chemokines in Atherosclerosis Proceedings Resumed Brief Review

  year unknowncites this paper
• Zernecke and Weber Chemokines in Atherosclerosis 743

  year unknowncites this paper